Skip to main navigation Skip to search Skip to main content

Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma

  • Thomas Powles
  • , Se Hoon Park
  • , Eric Voog
  • , Claudia Caserta
  • , Begoña P. Valderrama
  • , Howard Gurney
  • , Haralabos Kalofonos
  • , Siniša Radulović
  • , Wim Demey
  • , Anders Ullén
  • , Yohann Loriot
  • , Srikala S. Sridhar
  • , Norihiko Tsuchiya
  • , Evgeny Kopyltsov
  • , Cora N. Sternberg
  • , Joaquim Bellmunt
  • , Jeanny B. Aragon-Ching
  • , Daniel P. Petrylak
  • , Robert Laliberte
  • , Jing Wang
  • Bo Huang, Craig Davis, Camilla Fowst, Nuno Costa, John A. Blake-Haskins, Alessandra Di Pietro, Petros Grivas
  • Queen Mary University of London
  • Victor Hugo Clinic–Jean Bernard Center
  • Azienda Ospedaliera S. Maria di Terni
  • Hospital Universitario Virgen del Rocio
  • Macquarie University
  • University General Hospital of Patras
  • Institute for Oncology and Radiology of Serbia
  • Algemeen Ziekenhuis Klina
  • Karolinska Institutet
  • Gustave Roussy
  • Princess Margaret Cancer Centre
  • Yamagata University
  • State Institution of Healthcare Regional Clinical Oncology Dispensary
  • Cornell University
  • Harvard University
  • Inova Schar Cancer Institute
  • Yale University
  • Pfizer
  • University of Washington
  • Seattle Cancer Care Alliance

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology